ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of the Pre-Admission Medication List (PAML) Builder Reminder Prompts (PAMLTIPS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00657462
Recruitment Status : Completed
First Posted : April 14, 2008
Last Update Posted : January 31, 2017
Sponsor:
Collaborator:
Massachusetts General Hospital
Information provided by (Responsible Party):
Alexander Turchin, Brigham and Women's Hospital

Brief Summary:
This project will study whether reminder prompts increase PAML Builder application feature utilization.

Condition or disease Intervention/treatment Phase
Utilization of Software Application Features Other: Reminders Not Applicable

Detailed Description:

This project will study whether reminder prompts increase Pre-Admission Medication List (PAML) Builder application feature utilization. PAML Builder is an application designed and maintained by Partners Information Systems that assists clinicians in medication reconciliation - a process important for patient safety and quality of care. We have determined that several potentially helpful features of the application are not being utilized as frequently as had been expected. These features include:

  1. copying the pre-admission medication list (PAML) to the clipboard
  2. viewing the detailed audit trail of all changes made to the PAML
  3. sorting the list of medications obtained from other electronic sources by therapeutic class.

Reminder prompts (sometimes referred to as "Tip of the Day") have been employed to increase user awareness of underutilized application features. However, anecdotally some users find them unhelpful and potentially irritating. It is therefore important to determine whether reminder prompts accomplish the stated task of increasing application feature utilization. This project will compare PAML Builder application feature utilization before and after a pilot rollout of reminder prompts to determine whether they should be implemented permanently.


Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 14122 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Effect of Reminder Prompts on Utilization of the PAML Builder Application Features
Study Start Date : April 2008
Actual Primary Completion Date : July 2008
Actual Study Completion Date : July 2008

Arm Intervention/treatment
Experimental: A
Receives the intervention (reminders displayed at the startup of the application) for both periods (period 1 and period 2) of the study.
Other: Reminders
Users of the PAML Builder application will receive reminders about three application features (copy/paste, audit trail, sort medications by class) at the startup of the application
Active Comparator: B
Receives the intervention (reminders displayed at the application startup) only during the second period (period 2) of the study.
Other: Reminders
Users of the PAML Builder application will receive reminders about three application features (copy/paste, audit trail, sort medications by class) at the startup of the application



Primary Outcome Measures :
  1. Difference in the change between combined frequency of utilization of all features promoted by the reminders per PAML built between the two arms from period 1 (intervention in one arm only) to period 2 (intervention in both arms). [ Time Frame: The entire study period ]

Secondary Outcome Measures :
  1. Difference in the change between frequencies of utilization of the individual features promoted by the reminders per PAML built between the two arms from period 1 (intervention in one arm only) to period 2 (intervention in both arms). [ Time Frame: The entire study period ]
  2. Difference in the change between combined frequency of utilization of all features promoted by the reminders per PAML built between the two arms from period 1 to period 2 by the users who were displayed the corresponding reminder. [ Time Frame: The entire study period ]
  3. Difference in the change between frequencies of utilization of the individual features promoted by the reminders per PAML built between the two arms from period 1 to period 2 by the users who were displayed the corresponding reminders. [ Time Frame: The entire study period. ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • users of the PAML Builder application (physicians, nurses, pharmacists)

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00657462


Locations
United States, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
Sponsors and Collaborators
Brigham and Women's Hospital
Massachusetts General Hospital
Investigators
Principal Investigator: Alexander Turchin, MD, MS Partners HealthCare
Principal Investigator: Carol Broverman, PhD Partners HealthCare